Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (DHR)
NYSE:DHR
DHR Stock Chart & Stats
$216.61
-$1.72(-0.72%)
At close: 4:00 PM EST
$216.61
-$1.72(-0.72%)
Day’s Range― - ―
52-Week Range$171.00 - $242.80
Previous CloseN/A
Volume816.38K
Average Volume (3M)3.48M
Market Cap
$153.00B
Enterprise Value$166.92B
Total Cash (Recent Filing)$4.62B
Total Debt (Recent Filing)$18.42B
Price to Earnings (P/E)42.9
Beta0.84
Next Earnings
Apr 28, 2026EPS Estimate
1.94Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)2.23
Shares Outstanding706,349,550
10 Day Avg. Volume5,099,312
30 Day Avg. Volume3,479,392
Financial Highlights & Ratios
PEG Ratio-9.18
Price to Book (P/B)3.08
Price to Sales (P/S)6.59
P/FCF Ratio30.78
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue6.79
Enterprise Value/Gross Profit11.15
Enterprise Value/Ebitda24.04
Forecast
1Y Price Target
$266.18Price Target Upside22.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)8.41
Revenue Forecast (FY)$25.61B
Bulls Say, Bears Say
Bulls Say
Balance Sheet And M&AStrong cash flow and a primed balance sheet increase the likelihood of strategic acquisitions that could expand higher-margin offerings and accelerate growth.
Bioprocessing DemandRising orders for bioprocessing equipment alongside steady consumables demand support above-average revenue growth and strengthen recurring revenue visibility.
Cost Structure And MarginsAccelerated cost reductions and disciplined reinvestment have improved operating margins and create clearer potential for earnings upside as markets recover.
Bears Say
End-market WeaknessPersistent softness in life science instruments, discovery businesses, and some diagnostic markets could slow the recovery in organic revenue and dampen growth forecasts.
Guidance And Management ConservatismConservative forward guidance driven by a cautious management stance can weigh on sentiment and limit upside if end-market recovery is uneven.
Valuation SensitivityShares trading at a premium to peers increase downside risk if growth does not accelerate or equipment and China diagnostic demand fail to improve.
Danaher News
DHR FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest stock price was $171.00 and its highest was $242.80 in the past 12 months.
What is Danaher Corp.’s market cap?
Danaher Corp.’s market cap is $153.00B.
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Apr 28, 2026 which is in 77 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Jan 28, 2026. The company reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.163 by $0.067.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.32 which represents an annual dividend yield of 0.53%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is 1.94.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 706,349,550 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $2.23 in its last earnings report, beating expectations of $2.163. Following the earnings report the stock price went down -4.755%.
Which hedge fund is a major shareholder of Danaher Corp.?
Currently, no hedge funds are holding shares in DHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Danaher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$266.18 (22.88% Upside)
$266.18 (22.88% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 5.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $115.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.79%
12-Months-Change
Fundamentals
Return on Equity
7.05%
Trailing 12-Months
Asset Growth
7.64%
Trailing 12-Months
Company Description
Danaher Corp.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
DHR Company Deck
DHR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized durable strengths: robust free cash flow ($5.3B), consecutive EPS and margin resilience, strong product innovation (new product revenue ~+25% YoY), and clear momentum in bioprocessing and diagnostics (Cepheid, Beckman, Leica, Radiometer). Management acknowledged Q4 margin compression (-130 bps) and pockets of weakness in life sciences consumables, academic funding, equipment orders (still below historical levels) and China policy headwinds, and set conservative FY2026 guidance (3%–6% core growth, EPS $8.35–$8.50). On balance, the company presented improving end-market momentum, disciplined cost actions (~$250M) and strong balance sheet flexibility to pursue M&A, while remaining appropriately cautious on near-term variability and execution risks.View all DHR earnings summariesDHR Revenue Breakdown
28.31% Biotechnology
30.70% Life Sciences
40.99% Diagnostics
DHR Stock 12 Month Forecast
Average Price Target
$266.18
▲(22.88% Upside)
Technical Analysis
Ownership Overview
8.74% Insiders
25.18% Mutual Funds
0.20% Other Institutional Investors
47.14% Public Companies and Individual Investors